Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

In the rapidly evolving field of genetic engineering, few names resonate as profoundly as George Church, a geneticist at Harvard University. Known for his groundbreaking work in genomics, Church has ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...